Cytokineticsorporated Total Assets 2006-2020 | CYTK

Cytokineticsorporated total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cytokineticsorporated Annual Total Assets
(Millions of US $)
2019 $290
2018 $211
2017 $295
2016 $170
2015 $115
2014 $133
2013 $83
2012 $78
2011 $53
2010 $78
2009 $123
2008 $87
2007 $155
2006 $170
2005 $91
Cytokineticsorporated Quarterly Total Assets
(Millions of US $)
2020-09-30 $474
2020-06-30 $232
2020-03-31 $257
2019-12-31 $290
2019-09-30 $187
2019-06-30 $198
2019-03-31 $199
2018-12-31 $211
2018-09-30 $230
2018-06-30 $247
2018-03-31 $280
2017-12-31 $295
2017-09-30 $326
2017-06-30 $341
2017-03-31 $265
2016-12-31 $170
2016-09-30 $158
2016-06-30 $106
2016-03-31 $113
2015-12-31 $115
2015-09-30 $102
2015-06-30 $113
2015-03-31 $122
2014-12-31 $133
2014-09-30 $87
2014-06-30 $96
2014-03-31 $107
2013-12-31 $83
2013-09-30 $88
2013-06-30 $95
2013-03-31 $65
2012-12-31 $78
2012-09-30 $85
2012-06-30 $94
2012-03-31 $47
2011-12-31 $53
2011-09-30 $62
2011-06-30 $72
2011-03-31 $66
2010-12-31 $78
2010-09-30 $83
2010-06-30 $95
2010-03-31 $112
2009-12-31 $123
2009-09-30 $134
2009-06-30 $144
2009-03-31 $93
2008-12-31 $87
2008-09-30 $100
2008-06-30 $119
2008-03-31 $138
2007-12-31 $155
2007-09-30 $169
2007-06-30 $173
2007-03-31 $187
2006-12-31 $170
2006-09-30 $105
2006-06-30 $110
2006-03-31 $115
2005-12-31 $91
2005-09-30 $96
2005-06-30 $105
2005-03-31 $118
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.121B $0.027B
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility. Cytokinetics' lead drug candidate is tirasemtiv, a fast skeletal muscle activator, for the potential treatment of ALS. Tirasemtiv has been granted orphan drug designation and fast track status by the FDA and orphan medicinal product designation by the EMA. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.490B 10.02
Amgen (AMGN) United States $130.796B 13.67
CSL (CSLLY) Australia $103.933B 0.00
Gilead Sciences (GILD) United States $76.001B 10.10
Vertex Pharmaceuticals (VRTX) United States $55.120B 25.63
Regeneron Pharmaceuticals (REGN) United States $54.923B 19.48
Illumina (ILMN) United States $43.654B 60.04
Biogen (BIIB) United States $37.549B 6.67
Moderna (MRNA) United States $36.710B 0.00
Seagen (SGEN) United States $31.440B 83.03
Alexion Pharmaceuticals (ALXN) United States $26.710B 10.64
BeiGene (BGNE) Cayman Islands $25.597B 0.00
Genmab (GMAB) Denmark $23.665B 28.01
Genmab (GNMSF) Denmark $22.484B 5.18
BioNTech SE (BNTX) Germany $21.479B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Incyte (INCY) United States $17.890B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.776B 67.41
Exact Sciences (EXAS) United States $17.025B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.690B 22.43
Alnylam Pharmaceuticals (ALNY) United States $14.384B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.638B 90.52
ARGENX SE-ADR (ARGX) Netherlands $12.417B 0.00
Bio-Techne Corp (TECH) United States $11.670B 74.63
Mirati Therapeutics (MRTX) United States $11.407B 0.00
Guardant Health (GH) United States $10.848B 0.00
QIAGEN (QGEN) Netherlands $10.766B 24.24
Sarepta Therapeutics (SRPT) United States $10.607B 0.00
Repligen (RGEN) United States $9.855B 139.77
ACADIA Pharmaceuticals (ACAD) United States $8.523B 0.00
Galapagos (GLPG) Belgium $8.062B 0.00
Ascendis Pharma (ASND) Denmark $7.990B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.718B 0.00
Denali Therapeutics (DNLI) United States $7.405B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.887B 0.00
Acceleron Pharma (XLRN) United States $6.683B 0.00
Adaptive Biotechnologies (ADPT) United States $6.225B 0.00
Exelixis (EXEL) United States $5.895B 39.58
Amicus Therapeutics (FOLD) United States $5.660B 0.00
Reata Pharmaceuticals (RETA) United States $5.550B 0.00
Novavax (NVAX) United States $5.500B 0.00
Blueprint Medicines (BPMC) United States $5.390B 17.84
SWEDISH ORP BIO (BIOVF) Sweden $5.385B 14.71
Halozyme Therapeutics (HALO) United States $5.214B 241.06
Twist Bioscience (TWST) United States $5.114B 0.00
NeoGenomics (NEO) United States $4.744B 1424.33
China Biologic Products (CBPO) China $4.664B 27.69
Fate Therapeutics (FATE) United States $4.337B 0.00
Emergent Biosolutions (EBS) United States $4.270B 14.01
Insmed (INSM) United States $4.047B 0.00
Arena Pharmaceuticals (ARNA) United States $3.826B 0.00
Vir Biotechnology (VIR) United States $3.659B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.643B 0.00
Legend Biotech (LEGN) United States $3.509B 0.00
MorphoSys AG (MOR) Germany $3.473B 125.71
Eidos Therapeutics (EIDX) United States $3.105B 0.00
Bluebird Bio (BLUE) United States $2.931B 0.00
Seres Therapeutics (MCRB) United States $2.925B 0.00
Alkermes (ALKS) Ireland $2.892B 28.39
Global Blood Therapeutics (GBT) United States $2.686B 0.00
I-Mab (IMAB) China $2.298B 0.00
Beam Therapeutics (BEAM) United States $2.291B 0.00
Intra-Cellular Therapies (ITCI) United States $2.082B 0.00
UniQure (QURE) Netherlands $2.054B 0.00
PHARMA MAR SA (PHMMF) Spain $2.028B 0.00
Sorrento Therapeutics (SRNE) United States $2.011B 0.00
Viela Bio (VIE) United States $1.914B 0.00
Intellia Therapeutics (NTLA) United States $1.906B 0.00
Zymeworks (ZYME) Canada $1.902B 0.00
Inovio Pharmaceuticals (INO) United States $1.867B 0.00
Amarin (AMRN) Ireland $1.775B 0.00
Editas Medicine (EDIT) United States $1.747B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Revance Therapeutics (RVNC) United States $1.624B 0.00
Mersana Therapeutics (MRSN) United States $1.608B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
NGM Biopharmaceuticals (NGM) United States $1.605B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.594B 0.00
Arcus Biosciences (RCUS) United States $1.578B 0.00
Sangamo Therapeutics (SGMO) United States $1.460B 0.00
Alcobra (ARCT) United States $1.454B 0.00
Zealand Pharma (ZEAL) Denmark $1.434B 0.00
Mesoblast (MESO) Australia $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
Scholar Rock Holding (SRRK) United States $1.346B 0.00
Ligand Pharmaceuticals (LGND) United States $1.311B 33.97
Athenex (ATNX) United States $1.303B 0.00
Myriad Genetics (MYGN) United States $1.293B 0.00
Coherus BioSciences (CHRS) United States $1.291B 8.53
Zealand Pharma (ZLDPF) Denmark $1.289B 0.00
Adverum Biotechnologies (ADVM) United States $1.236B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.229B 0.00
Heska (HSKA) United States $1.167B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Precigen (PGEN) United States $1.139B 0.00
Vericel (VCEL) United States $1.074B 0.00
Northwest Biotherapeutics (NWBO) United States $1.050B 0.00
Genetron Holdings (GTH) China $1.025B 0.00
Alector (ALEC) United States $0.979B 0.00
Codexis (CDXS) United States $0.976B 0.00
Pliant Therapeutics (PLRX) United States $0.971B 0.00
Arvinas (ARVN) United States $0.947B 0.00
Cellectis S.A (CLLS) France $0.939B 0.00
NantKwest (NK) United States $0.923B 0.00
Castle Biosciences (CSTL) United States $0.921B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.911B 0.00
Morphic Holding (MORF) United States $0.908B 0.00
Compugen (CGEN) Israel $0.883B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.880B 0.00
Protagonist Therapeutics (PTGX) United States $0.823B 0.00
Frequency Therapeutics (FREQ) United States $0.815B 0.00
Cara Therapeutics (CARA) United States $0.794B 0.00
Celldex Therapeutics (CLDX) United States $0.791B 0.00
MiMedx (MDXG) United States $0.754B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
AnaptysBio (ANAB) United States $0.718B 0.00
Agenus (AGEN) United States $0.713B 0.00
Five Prime Therapeutics (FPRX) United States $0.691B 0.00
Sutro Biopharma (STRO) United States $0.688B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.682B 34.64
Kadmon Holdings (KDMN) United States $0.669B 0.00
Albireo Pharma (ALBO) United States $0.665B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.663B 0.00
MannKind (MNKD) United States $0.642B 0.00
VBI Vaccines (VBIV) United States $0.641B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.614B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.598B 0.00
Cardiff Oncology (CRDF) United States $0.589B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.587B 0.00
Geron (GERN) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.519B 70.27
Aquinox Pharmaceuticals (NLTX) United States $0.512B 0.00
Forte Biosciences (FBRX) United States $0.508B 0.00
Precision BioSciences (DTIL) United States $0.508B 0.00
IVERIC Bio (ISEE) United States $0.507B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.505B 0.00
Avid Bioservices (CDMO) United States $0.504B 0.00
MeiraGTx Holdings (MGTX) United States $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.471B 0.00
Amryt Pharma (AMYT) United Kingdom $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.449B 0.00
Cel-Sci (CVM) United States $0.439B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.432B 0.00
WAVE Life Sciences (WVE) Singapore $0.428B 0.00
Kala Pharmaceuticals (KALA) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.415B 19.52
Innate Pharma S.A (IPHA) France $0.402B 0.00
Spero Therapeutics (SPRO) United States $0.402B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Starpharma Holdings (SPHRY) Australia $0.397B 0.00
Trevena (TRVN) United States $0.385B 0.00
Cue Biopharma (CUE) United States $0.385B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 0.00
Clovis Oncology (CLVS) United States $0.379B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
Affimed (AFMD) Germany $0.368B 0.00
Syros Pharmaceuticals (SYRS) United States $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
XOMA (XOMA) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.347B 0.00
Selecta Biosciences (SELB) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.76
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Athersys (ATHX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.297B 13.92
IBio (IBIO) United States $0.295B 0.00
Arbutus Biopharma (ABUS) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.281B 0.00
NextCure (NXTC) United States $0.275B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Fortress Biotech (FBIO) United States $0.259B 0.00
Verastem (VSTM) United States $0.250B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
TELA Bio (TELA) United States $0.237B 0.00
Pluristem Therapeutics (PSTI) Israel $0.235B 0.00
CorMedix Inc (CRMD) United States $0.219B 0.00
Aptinyx (APTX) United States $0.201B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Bellus Health (BLU) Canada $0.192B 0.00
Aptevo Therapeutics (APVO) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.182B 0.00
Dyadic (DYAI) United States $0.181B 0.00
Eton Pharmaceuticals (ETON) United States $0.178B 0.00
Theratechnologies (THTX) Canada $0.178B 0.00
AquaBounty Technologies (AQB) United States $0.174B 0.00
Strongbridge Biopharma (SBBP) United States $0.173B 0.00
Cerecor (CERC) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.170B 0.00
Nicox SA (NICXF) France $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.169B 0.00
Checkpoint Therapeutics (CKPT) United States $0.168B 0.00
VolitionRX (VNRX) United States $0.166B 0.00
Biofrontera AG (BFRA) Germany $0.163B 0.00
GENFIT S.A (GNFT) France $0.160B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
SESEN BIO, INC (SESN) United States $0.149B 0.00
Kindred Biosciences (KIN) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.138B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
Abeona Therapeutics (ABEO) United States $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.130B 0.00
Protalix BioTherapeutics (PLX) Israel $0.130B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
Exicure (XCUR) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.127B 0.00
Idera Pharmaceuticals (IDRA) United States $0.127B 0.00
Celyad SA (CYAD) Belgium $0.123B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
TRACON Pharmaceuticals (TCON) United States $0.117B 0.00
Aytu Bioscience (AYTU) United States $0.116B 0.00
Orgenesis (ORGS) United States $0.114B 235.00
Novogen (KZIA) Australia $0.114B 0.00
Cogent Biosciences (COGT) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.109B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.108B 0.00
Applied Genetic Technologies (AGTC) United States $0.105B 0.00
Gritstone Oncology (GRTS) United States $0.103B 0.00
Cyclerion Therapeutics (CYCN) United States $0.103B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.078B 0.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 37.00
Curis (CRIS) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Soligenix (SNGX) United States $0.072B 0.00
Evogene (EVGN) Israel $0.072B 0.00
MiRagen Therapeutics (MGEN) United States $0.072B 0.00
Adocia (ADOCY) France $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Emmaus Life Sciences (EMMA) United States $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Happiness Biotech Group (HAPP) China $0.049B 0.00
Edesa Biotech (EDSA) Canada $0.047B 0.00
Vaccinex (VCNX) United States $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Seelos Therapeutics (SEEL) United States $0.043B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
Genetic Technologies (GENE) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
Titan Pharmaceuticals (TTNP) United States $0.034B 0.00
OvaScience (MLND) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
Celsion (CLSN) United States $0.019B 0.00
Spherix (AIKI) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.011B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00